Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sulzer Orthopedics was a leading manufacturer of orthopedic implants, specializing in hip, knee, and shoulder replacement systems. Originally a subsidiary of the Swiss industrial group Sulzer AG and later part of Sulzer Medica, the company was a major competitor in the global musculoskeletal market. It is historically significant for a large-scale voluntary recall in 2000 involving hip and knee implants contaminated with lubricant residue, which led to extensive litigation. In 2002, the parent company rebranded as Centerpulse to distance itself from the legal challenges. Centerpulse was subsequently acquired by Zimmer Holdings in 2003 for approximately $3.2 billion. Today, its legacy products and technologies are integrated into the Zimmer Biomet portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sulzer Orthopedics.